After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.

Plantar fasciitis has ended Egor Dëmin’s rookie season. A successful procedure has the Nets guard already looking toward the ...

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of ...

A new study found that an algorithm created by UC San Francisco researchers helped improve the health of thousands of Californians and prevented dozens of deaths. The study, published Wednesday in the ...

Clonal hematopoiesis in chronic lymphocytic leukemia is widespread, shaping cytopenias, cardiovascular risk, and chemotoxicity. As patients age on therapy for their chronic lymphocytic leukemia (CLL), ...

A machine learning algorithm estimated 995,787 deaths caused by COVID-19 in the U.S. from March 2020 to December 2021 -- 19% more than official reports. COVID deaths in seniors were likely 21% to 22% ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep ...

Oscars 2026 leaves audience stunned with rare moment seen only 7 times in 100 years | Find out UAE: CBSE cancels class XII exams from March 16-April 10 in seven GCC countries amid regional tensions ...

Facing the loss of his beloved rescue dog, a tech entrepreneur enlisted AI and ChatGPT to co-develop an experimental cancer vaccine.

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...

A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...